Answers are grounded in this paper and cite their sources.
In recent years, the incidence of Inflammatory Bowel Disease (IBD) has risen significantly in the Western population, pointing toward the potential influence of environmental and dietary factors. In order to explain this, some research on nutritional therapy identifies exclusive enteral nutrition (EEN) as a highly effective approach for managing IBD in children. This treatment achieves high remission rates; more specifically, some clinical trials have reported remission rates from 70% to 100%. EEN not only facilitates mucosal healing but also exhibits a safer profile than corticosteroids (CS) and supports improved nutritional outcomes. After understanding the role of the microbiota in IBD, it has been discovered that EEN plays a fundamental role in modulating the microbiota and, consequently, the inflammatory response, reducing pro-inflammatory microbiota. Despite these promising effects, the implementation of EEN in clinical settings remains inconsistent across different regions and clinical guidelines. This narrative review seeks to gather and analyze the current literature on EEN and its impact on IBD, clarifying its mechanisms of action and examining its potential roles in different scenarios, such as pediatric Crohn’s disease, adult treatment regimens, preoperative care, and ulcerative colitis (UC) management.
No takes yet. Share an insight, caveat, or question.
González et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: